PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAF9J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,186
Award facts
- Contract value 100% obligated
- $12,185.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 19, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) represents a $12,185.65 firm fixed-price task order issued under the Defense Logistics Agency (DLA) Troop Support Medical's Pharmaceutical Prime Vendor Global Program contract, which carries a ceiling value of $999,999,999.00 through December 2026. The award was made on a non-set-aside, fully competitive basis and is set for ultimate completion by January 20, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which also serves as the place of performance for this order—is a major pharmaceutical distributor and critical federal vendor supplying pharmaceutical products and medical supplies to military and veteran healthcare systems.
As a child contract under the DLA Troop Support Medical IDC, this delivery order is part of AmerisourceBergen's broader portfolio supporting federal medical procurement across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's parent organization, Cencora, Inc., holds the primary $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, positioning AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and the contract's alignment with DLA's pharmaceutical supply chain demonstrate the company's proven capability to meet federal medical supply requirements efficiently and competitively.
Quick answers
Who was awarded contract SPE2D826FAF9J?
SPE2D826FAF9J was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826FAF9J worth?
The government has obligated $12,186 on SPE2D826FAF9J.
Is contract SPE2D826FAF9J an order under another contract?
Yes. SPE2D826FAF9J is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAF9J competed?
The extent of competition for SPE2D826FAF9J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award